Christina Chan
Senior Vice President, Corporate AffairsRegeneron Pharmaceuticals
PharmaceuticalsView Profile →Head of Investor Relations · Biogen
Tim Power leads investor relations at Biogen, following a long Bristol Myers Squibb career and earlier strategy consulting and engineering work.
Last reviewed: Nov 2, 2026
Head of Investor Relations
Biogen
Last Reviewed: November 2, 2026
Tim Power leads investor relations at Biogen, following a long Bristol Myers Squibb career and earlier strategy consulting and engineering work.
Power began his career in engineering in the energy industry. He later became a senior consultant at Strategic Decisions Group, advising clients in life sciences and energy on corporate strategy, asset optimization and portfolio planning.
He spent more than 18 years at Bristol Myers Squibb, working across investor relations, corporate finance and strategic planning. The company announced his appointment as vice president and head of investor relations in December 2019, with the role taking effect on March 31, 2020, when John Elicker retired.
In that position, Power led communications and engagement with the investment community and reported to CFO David Elkins. His leadership of investor relations followed Bristol Myers Squibb’s 2019 acquisition of Celgene and included work supporting the combined organization’s shareholder engagement.
Power joined Biogen in 2024 as head of investor relations.
Power holds a B.Eng. in chemical engineering from University College Dublin, a Ph.D. in chemical engineering from Carnegie Mellon University and an MBA in finance from the University of Pennsylvania’s Wharton School.